Marken Offers Exclusive GPS Technology For Shipments
-- The Advanced Tracking Device Delivers Real Time Monitoring for a Variety of Conditions
RESEARCH TRIANGLE PARK, North Carolina, Aug. 11, 2015 /PRNewswire/ -- Marken, the leading clinical logistics organization (CLO), has entered into an exclusive agreement with OnAsset Intelligence Inc. for use of their most advanced GPS tracking device on key shipments. The device will significantly improve Marken's real-time, track and trace capability through custom-designed software.
Logo - http://photos.prnewswire.com/prnh/20110930/NY78064LOGO
Marken will offer clients a continuous, shipment-specific device which will track the location of each shipment in real time. In addition to reporting its location, the device will report its temperature, motion & shock, light exposure (open box), atmospheric pressure and remaining battery life. Marken will also offer geo-fencing at all airports and can customize geo-fence waypoints and status updates for each validated shipping lane. The device transmits in real time and communicates through customized cloud based software. The device and software are protected by over 15 approved patents and is approved for use on more than 40 airlines.
Marken made the decision to take this step to further demonstrate the company's commitment to high value clinical trial drug substance and drug product which are increasingly derived from sensitive biologic material.
Marken's Chief Executive Officer, Wes Wheeler, commented on the announcement. "Marken believes that by offering this state-of-the-art tracking device, we have taken an important and necessary step which guarantees the safe delivery of each drug shipment. Marken is committed to providing the latest technology available, and we believe we have found it with OnAsset. Our agreement with OnAsset also comes at an important time in our industry, where GDP compliance is becoming a mandate in our industry. It also allows us to comply with recent updates to Annex 15 in Europe."
Adam Crossno, OnAsset Intelligence Chief Executive Officer adds, "We are very excited to be working with Marken. OnAsset's SENTRY FlightSafe® devices, Vision Platform and real time tracking and monitoring across all modes of transport combined with Marken's industry-leading services and Maestro software are a powerful solution that is unmatched in the marketplace. Being part of the Marken team that is providing a holistic suite of services that offers compliance with global regulations, security and real time validation for such important shipments is game changing. We look forward to showing the world the combined power of real time technology and logistics service excellence."
About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates depot and logistics into solutions that extend the reach of clinical trials to even the most remote treatment-naive geographies. Marken is 100% dedicated to the clinical research industry and a specialist in the transportation of investigational medical products and medical devices. In addition to services such as the storage and distribution of clinical trial materials and drug products to investigators or the patients directly, Marken maintains a leading position for the shipment of biological samples and offers additional services such as shipment lane qualifications as well as GDP, regulatory and compliance consultancy.
www.marken.com
About OnAsset Intelligence
OnAsset Intelligence is the global leader in real time asset tracking services. The company manufactures wireless devices that monitor all modes of transport including land, sea and air. Products and services include SENTRY wireless hardware and the Vision™ Monitoring Platform. Its flagship product, SENTRY FlightSafe®, is approved by commercial and cargo operators across the globe. OnAsset currently holds 15 awarded patents for its technology.
www.onasset.com
Share this article